INSIDE PHARMA enters a new phase, as the SARS-CoV-2 sterile injectables, that were not sterile, need purging
Where are all the chemicals and components that were scattered around the globe in their billions of tons? The next task is to find out what's in the supply chain, and make sure it's safe.
INSIDE PHARMA’s New Phase
Subscribers may remember the below—Transforming the Pharmaceutical Supply Chain, Wiley, 2024: All you ever wanted to know about pharmaceutical supply chain management, fact not fiction.
On the personal front, it has been a cathartic moment to reach the point where the final manuscript has been uploaded to the Wiley publishing machinery. It went up yesterday and today I’m having a rest and updating you all.
Next stage is production of the book and I’m told it is likely to be late summer when it is published. Will update on progress as ans when.
You may be wondering why this is a cathartic moment?
This is why it’s cathartic. I have spent the last fifteen years blowing the whistle on poor practices in pharmaceutical supply chain management, to those inside the industry. Not just blowing the damn thing, but giving presentations at industry conferences in the US and EU. Some examples here:
“Supply Chain Transparency and Pedigree”, Food and Drug Administration/Xavier University Global Outsourcing Conference April 28, 2010.
“The Power of Integrated Supply Chains, by Design,” 34th International GMP Conference, University of Georgia, March 14, 2012.
“Quality by Design (QbD) - The Route to Supply Chain Transformation”, Conference on QbD/PAT: Cortona (Tuscany), Italy, October 2012
“Building, Managing and Continuously Improving Clinical Supply Chains”, IQPC Clinical Trial Supply Europe, Basel, 2012.
“Good Distribution Practices: What do they mean to you?” International Society for Pharmaceutical Engineering (ISPE) Annual Conference, San Francisco, November, 2012.
“Is the Pharma Supply Chain a Lost Cause?” QUMAS CONNECT, Tampa, Florida, February 2013.
“Implementing Quality by Design (QbD) like other industries – successfully!” FDA/Xavier University, PharmaLink Conference, Cincinnati, March 2013.
“De-risking the Pharma Supply Chain from Day 1…” Jardine Lloyd Thomson(JLT) Insurance Annual Conference, Windsor, UK May 2014.
“A Provider Perspective on Building Patient-Centric Supply Chains”, UPS EU Healthcare Annual Conference, Hungarian Academy of Science, Budapest, October 2014.
There were more of course, but these should give you a flavour.
I only ever had travel costs reimbursed, and more often than not, they were less than the out-of-pocket expenses incurred. I was doing it in the name of raising awareness of the serious issues lurking in the pharmaceutical supply chain, oh, and in the hope of selling a few copies of Supply Chain Management in the Drug Industry: Delivering Patient Value for Pharmaceuticals and Biologics.
Before I reduce you to tears with tales of self-sacrifice, let’s move to the positive, while recognising the negative of the recent past. Who could forget the impact of the SARS-CoV-2 injections that were cobbled together in record time?
The positive, if you could call it that, is the industry exposing itself for what is had become, and still is. Not only that, but the British Pharmaceutical Industry, aided and abetted by British government, clearly being the center of the global rollout of the jabs. More on the horrible outcome here:
Transforming the Pharmaceutical Supply Chain—what’s it about?
It is in three sections:
SECTION 1 BUILDING A KNOWLEDGE FOUNDATION
“The development of general ability for independent thinking and judgment should always be placed foremost, not the acquisition of special knowledge.”
—Albert Einstein
SECTION II: THE BLOCKBUSTER ERA
“Insanity: doing the same thing over and over again and expecting different results.”
—Albert Einstein
SECTION III: JOURNEY TO SUPPLY CHAIN TRANSFORMATION
“We cannot solve our problems with the same thinking we used when we created them.”
—Albert Einstein
The principle of the book
The Introduction concludes:
More than a generation of change will be required
The final point to take from this book is the scale of the change required. You will learn here that the steady decline for pharmaceutical companies started around four decades ago. It will take at least that amount of time while systems of education catch up, executives acquire new skills and competencies, industry professionals respond to revised ways of working and stakeholders club together in collaborative ways that have previously remained untapped.
There is no quick fix on offer here. It is now time to write all this up. Let’s get on with it.
Well, I got on with it, and will keep you updated moving forward.
Two final points
Point 1 is that Wiley is an academic publisher, with global reach and a well-defined target market for the book:
Subject Matter: Pharmaceutical science and industry
Level and Readership: Graduate level students, researchers, and professionals
This is a massive component of the book being cathartic. At last, there will be an audience, in current and future generations, that understand the crucial importance of supply chains that insert initially unknown substances into human beings. Moreover, they will have the knowledge and tools to leverage that understanding to drive meaningful change for the future.
Point 2 is this. Many of the INSIDE PHARMA posts have been free since January 2022, given the need to share knowledge far and wide. There are over 6,150 subscribers to date, with 106 paying for their subscription.
To be fair to paying subscribers, I’ve decided to make all future posts paid, and potentially raise the price in a week or so, since currently it is as low as Substack allow ($5 pm or $40).
Non-paying subscribers can still find my self-published, reasonably priced books on Amazon, such as:
Kindle: THE COVID-19 SUPPLY CHAIN: Fact not Fiction
Paperback: COVID Supply Chains: Fact not Fiction
or:
Find It, File It, Flog It: Pharma's Crippling Addiction and How to Cure it
Best, Hedley.
Congratulations on the book! The whole supply chain is in a terrible state and needs building from bottom up. A lot of the chemicals are produced in India and Agent131711 substack reveals what's in vitamins and shows factories making the chemicals.
https://timothywiney.substack.com/p/who-wants-to-be-a-trillionaire